Chip Ganassi Racing Teams Unite With Novo Nordisk and Charlie Kimball's "Race with Insulin" Initiative

Chip Ganassi Racing Teams Unite With Novo Nordisk and Charlie Kimball's "Race
                           with Insulin" Initiative

2010 Daytona 500 Winner McMurray to drive No. 1 Race With Insulin Chevrolet at

PR Newswire

DAYTONA BEACH, Fla., Feb. 15, 2013

DAYTONA BEACH, Fla., Feb. 15, 2013 /PRNewswire/ --Chip Ganassi Racing Teams
(CGRT) and partnerNovo Nordisk, a world leader in diabetes care, announced
today that their IZOD IndyCar Series driver, Charlie Kimball (No. 83 Novo
Nordisk Honda), of the Race with Insulin™ program, has gained the support of
his fellow CGRT teammates across NASCAR, INDYCAR and GRAND-AM, combining for a
Race with Insulin™ Unites initiative.

To view the multimedia assets associated with this release, please click:


During the weekend of April 5-7, CGRT NASCAR Sprint Cup Series (NSCS) teammate
Jamie McMurray (No. 1 Chevrolet SS) and Kimball will sport Race with Insulin™ 
paint schemes at Martinsville Speedway and Barber Motorsports Park,
respectively, to show that with the right management plan and "team" support,
people with diabetes can start to get their diabetes on track.

In addition to the special paint schemes, all other CGRT cars (Juan Pablo
Montoya's No. 42 Chevrolet SS – NASCAR, Scott Dixon's No. 9 Honda – INDYCAR,
Dario Franchitti's No. 10 Honda – INDYCAR and Scott Pruett and Memo Rojas' No.
1 BMW – GRAND-AM) will run blue tire rims to help launch the Race with
Insulin™ Unites campaign. The rims will emulate a blue circle, which is the
International Diabetes Federation's (IDF) global symbol for diabetes, to
support Kimball's quest to educate more people about diabetes.

"If our team can help others understand that even with diabetes, you can live
life to the fullest, then we are glad to help," said Team Owner Chip Ganassi.
"Charlie is an emerging talent in the race car, and he is an even better human
being. A program like this speaks volumes about him."

According to the Centers for Disease Control and Prevention, approximately 26
million people are currently living with diabetes in the United States^i. For
many patients and their families, diabetes management can be daunting.

"Diabetes is one of the greatest health threats of our time," said President,
International Diabetes Federation, Sir Michael Hirst. "With the support of
such programs, we can begin to tackle a disease which is expected to affect
552 million people around the world by the year 2030."

Now in his third season with Novo Nordisk Chip Ganassi Racing, Kimball was
diagnosed with type 1 diabetes during a routine physician's visit in 2007
while racing in Europe. Kimball returned to the F3 Euroseries in April 2008
and finished second in his first race back after the diagnosis.

Determined to get back on the track, Kimball strategized with his doctor to
create some innovative solutions for keeping him safe and healthy in and out
of the race car. Along with diet and exercise, Charlie uses a pre-filled
insulin pen and a continuous glucose monitor to ensure that his diabetes is
properly managed, so that when he gets in the car, he can focus on racing.

"I am able to live my dream and compete in the IZOD IndyCar Series because I
have been fortunate to have the support of Novo Nordisk and my teammates, who
are extensions of my on-track pit crew," said Kimball, who recently became an
IDF Blue Circle Champion for diabetes. "Follow me at @racewithinsulin to learn
how you can enter to win a chance this year to become my honorary pit crew

Visit for more information. 

About Novo Nordisk
Headquartered in Denmark, Novo Nordisk is a global health care company with90
years of innovation and leadership in diabetes care. The company also has
leading positions within hemophilia care, growth hormone therapy, and hormone
replacement therapy. For more information, visit novonordisk-us.comor follow
our news in the US on Twitter: @NovoNordiskUS

About the International Diabetes Federation (IDF)
The International Diabetes Federation (IDF) is an umbrella organization of
over 200 national diabetes associations in over 160 countries. It represents
the interests of the growing number of people with diabetes and those at risk.
The Federation has been leading the global diabetes community since 1950.
IDF's mission is to promote diabetes care, prevention, and a cure worldwide. 

About Chip Ganassi Racing Teams
Chip Ganassi has been a fixture in the auto racing industry for over 25 years
and is considered one of the most successful, as well as innovative, owners
the sport has anywhere in the world. Today his teams include three cars in the
IZOD IndyCar Series, two cars in the NASCAR Sprint Cup Series, and one Daytona
Prototype in the GRAND-AM Rolex Sports Car Series. Overall, his teams have 15
championships and 150 victories, including four Indianapolis 500s, a Daytona
500, a Brickyard 400, and five Rolex 24 At Daytonas. Ganassi boasts
state-of-the-art race shop facilities in Indianapolis and Brownsburg, IN and
Concord, NC, with a corporate office in Pittsburgh, PA. For more information,
log on to

^i 2011 National Diabetes Fact Sheet. Centers for Disease Control Web site. Accessed November 28,
© 2013 Novo Nordisk All rights reserved. 0113-00012975-1 February 2013

SOURCE Novo Nordisk

Contact: Sarah Spielvogel, Novo Nordisk, +1-609-786-4278,; or Kelby Krauss, Chip Ganassi Racing, +1-317-802-0000,
Press spacebar to pause and continue. Press esc to stop.